3rd Quarter - Report

ROPES & GRAY, LLP for MEDICAL INFORMATION WORKING GROUP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$150,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Jan 6, 2015 $150,000 Replaced
3rd Quarter - Amendment Mar 10, 2015 $150,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Potential FDA Regulations and Policies Affecting the Dissemination of Information by Pharmaceutical and Medical Device Manufacturers

LobbyistCovered position, as disclosed
ALAN R. BENNETT —
KELLIE COMBS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

Potential Legislation Under the 21st Century Cures Initiative of the House Energy & Commerce Committee Affecting the Dissemination of Information by Pharmaceutical and Medical Device Manufacturers

LobbyistCovered position, as disclosed
ALAN R. BENNETT —
KELLIE COMBS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.